View Financial HealthNanoTIM 배당 및 자사주 매입배당 기준 점검 0/6NanoTIM 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-0.6%자사주 매입 수익률총 주주 수익률-0.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Mar 07NanoTIM Co. Ltd., Annual General Meeting, Mar 23, 2026NanoTIM Co. Ltd., Annual General Meeting, Mar 23, 2026, at 10:00 Tokyo Standard Time. Location: auditorium, 14, gukjegwahak 2-ro, yuseong-gu, daejeon South Korea분석 기사 • Jan 30NanoTIM Co. Ltd.'s (KOSDAQ:417010) 55% Share Price Surge Not Quite Adding UpNanoTIM Co. Ltd. ( KOSDAQ:417010 ) shares have continued their recent momentum with a 55% gain in the last month alone...분석 기사 • Dec 16There's Reason For Concern Over NanoTIM Co. Ltd.'s (KOSDAQ:417010) Massive 37% Price JumpNanoTIM Co. Ltd. ( KOSDAQ:417010 ) shareholders have had their patience rewarded with a 37% share price jump in the...분석 기사 • Dec 16NanoTIM Co. Ltd.'s (KOSDAQ:417010) 37% Share Price Surge Not Quite Adding UpNanoTIM Co. Ltd. ( KOSDAQ:417010 ) shareholders have had their patience rewarded with a 37% share price jump in the...New Risk • Dec 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 0.2% over the past year. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩131.7b market cap, or US$89.3m).Reported Earnings • Nov 19Third quarter 2025 earnings released: ₩20.00 loss per share (vs ₩94.00 loss in 3Q 2024)Third quarter 2025 results: ₩20.00 loss per share (improved from ₩94.00 loss in 3Q 2024). Revenue: ₩10.3b (up 52% from 3Q 2024). Net loss: ₩406.4m (loss narrowed 78% from 3Q 2024).공시 • Nov 14NanoTIM Co. Ltd. announced that it expects to receive KRW 10 billion in fundingNanoTIM Co. Ltd. announced a private placement of Unregistered Unsecured Private Convertible Bonds to raise gross proceeds of KRW 10,000,000,000 on November 13, 2025. The bonds are 100% convertible into 1,818,181 Common Shares of the company at a conversion of KRW 5,500. The transaction includes participation from investors 2024 IBK Innovation-AJU Good Venture Fund 3.0 for KRW 4,000,000,000, NH Investment & Securities Co., Ltd. for KRW 1,000,000,000, Korea Investment & Securities Co., Ltd for KRW 1,500,000,000, Samsung Securities Co., Ltd for KRW 1,700,000,000 and KB Securities Co., Ltd for KRW 1,800,000,000. The conversion billing period of the securities starts from November 21, 2026 through October 21, 2030. The bonds have a maturity date of November 21, 2030. The transaction is expected to close on November 21, 2025.Reported Earnings • Aug 19Second quarter 2025 earnings released: ₩0.076 loss per share (vs ₩27.00 loss in 2Q 2024)Second quarter 2025 results: ₩0.076 loss per share (improved from ₩27.00 loss in 2Q 2024). Revenue: ₩10.9b (up 23% from 2Q 2024). Net loss: ₩1.54m (loss narrowed 100% from 2Q 2024). Profit margin: 0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue.Reported Earnings • Mar 19Full year 2024 earnings released: ₩189 loss per share (vs ₩259 profit in FY 2023)Full year 2024 results: ₩189 loss per share (down from ₩259 profit in FY 2023). Revenue: ₩32.4b (down 31% from FY 2023). Net loss: ₩3.71b (down 176% from profit in FY 2023).공시 • Mar 07NanoTIM Co. Ltd., Annual General Meeting, Mar 24, 2025NanoTIM Co. Ltd., Annual General Meeting, Mar 24, 2025, at 10:00 Tokyo Standard Time. Location: auditorium, 14, gukjegwahak 2-ro, yuseong-gu, daejeon South KoreaNew Risk • Nov 20New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩135.5b (US$97.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.3% operating cash flow to total debt). Revenue has declined by 23% over the past year. Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (3.0% increase in shares outstanding). Market cap is less than US$100m (₩135.5b market cap, or US$97.0m).Reported Earnings • Nov 13Third quarter 2024 earnings released: ₩94.00 loss per share (vs ₩35.00 profit in 3Q 2023)Third quarter 2024 results: ₩94.00 loss per share (down from ₩35.00 profit in 3Q 2023). Revenue: ₩6.79b (down 36% from 3Q 2023). Net loss: ₩1.83b (down 380% from profit in 3Q 2023).분석 기사 • Oct 25Some Investors May Be Worried About NanoTIM's (KOSDAQ:417010) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...분석 기사 • Aug 25Is NanoTIM (KOSDAQ:417010) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Reported Earnings • Aug 13Second quarter 2024 earnings released: ₩27.00 loss per share (vs ₩77.00 profit in 2Q 2023)Second quarter 2024 results: ₩27.00 loss per share (down from ₩77.00 profit in 2Q 2023). Revenue: ₩8.87b (down 32% from 2Q 2023). Net loss: ₩522.9m (down 135% from profit in 2Q 2023).Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩9,980, the stock trades at a trailing P/E ratio of 52.9x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 53% over the past year.Buy Or Sell Opportunity • Jul 07Now 27% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.4% to ₩13,080. The fair value is estimated to be ₩17,912, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jul 05Now 27% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to ₩13,080. The fair value is estimated to be ₩17,927, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jul 05Now 27% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.5% to ₩13,050. The fair value is estimated to be ₩17,926, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jul 05Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.5% to ₩13,050. The fair value is estimated to be ₩17,733, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jul 04Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to ₩13,190. The fair value is estimated to be ₩17,754, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jul 02Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 10% to ₩13,190. The fair value is estimated to be ₩17,756, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jul 01Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 5.0% to ₩13,730. The fair value is estimated to be ₩17,762, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • Jun 21Now 21% undervaluedOver the last 90 days, the stock has risen 1.4% to ₩14,000. The fair value is estimated to be ₩17,716, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.Buy Or Sell Opportunity • May 31Now 21% undervaluedOver the last 90 days, the stock has risen 12% to ₩13,910. The fair value is estimated to be ₩17,599, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year. Earnings per share has grown by 2.5%.New Risk • Mar 22New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (50% accrual ratio). Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (3.0% increase in shares outstanding).분석 기사 • Mar 21We Think You Should Be Aware Of Some Concerning Factors In NanoTIM's (KOSDAQ:417010) EarningsNanoTIM Co. Ltd.'s ( KOSDAQ:417010 ) stock didn't jump after it announced some healthy earnings. We did some digging...New Risk • Nov 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 A417010 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: A417010 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장NanoTIM 배당 수익률 vs 시장A417010의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (A417010)n/a시장 하위 25% (KR)1.0%시장 상위 25% (KR)3.9%업계 평균 (Chemicals)1.3%분석가 예측 (A417010) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 A417010 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 A417010 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 A417010 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: A417010 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YKR 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 17:08종가2026/05/21 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스NanoTIM Co. Ltd.는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Mar 07NanoTIM Co. Ltd., Annual General Meeting, Mar 23, 2026NanoTIM Co. Ltd., Annual General Meeting, Mar 23, 2026, at 10:00 Tokyo Standard Time. Location: auditorium, 14, gukjegwahak 2-ro, yuseong-gu, daejeon South Korea
분석 기사 • Jan 30NanoTIM Co. Ltd.'s (KOSDAQ:417010) 55% Share Price Surge Not Quite Adding UpNanoTIM Co. Ltd. ( KOSDAQ:417010 ) shares have continued their recent momentum with a 55% gain in the last month alone...
분석 기사 • Dec 16There's Reason For Concern Over NanoTIM Co. Ltd.'s (KOSDAQ:417010) Massive 37% Price JumpNanoTIM Co. Ltd. ( KOSDAQ:417010 ) shareholders have had their patience rewarded with a 37% share price jump in the...
분석 기사 • Dec 16NanoTIM Co. Ltd.'s (KOSDAQ:417010) 37% Share Price Surge Not Quite Adding UpNanoTIM Co. Ltd. ( KOSDAQ:417010 ) shareholders have had their patience rewarded with a 37% share price jump in the...
New Risk • Dec 16New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Revenue has declined by 0.2% over the past year. Minor Risks Share price has been volatile over the past 3 months (10% average weekly change). Market cap is less than US$100m (₩131.7b market cap, or US$89.3m).
Reported Earnings • Nov 19Third quarter 2025 earnings released: ₩20.00 loss per share (vs ₩94.00 loss in 3Q 2024)Third quarter 2025 results: ₩20.00 loss per share (improved from ₩94.00 loss in 3Q 2024). Revenue: ₩10.3b (up 52% from 3Q 2024). Net loss: ₩406.4m (loss narrowed 78% from 3Q 2024).
공시 • Nov 14NanoTIM Co. Ltd. announced that it expects to receive KRW 10 billion in fundingNanoTIM Co. Ltd. announced a private placement of Unregistered Unsecured Private Convertible Bonds to raise gross proceeds of KRW 10,000,000,000 on November 13, 2025. The bonds are 100% convertible into 1,818,181 Common Shares of the company at a conversion of KRW 5,500. The transaction includes participation from investors 2024 IBK Innovation-AJU Good Venture Fund 3.0 for KRW 4,000,000,000, NH Investment & Securities Co., Ltd. for KRW 1,000,000,000, Korea Investment & Securities Co., Ltd for KRW 1,500,000,000, Samsung Securities Co., Ltd for KRW 1,700,000,000 and KB Securities Co., Ltd for KRW 1,800,000,000. The conversion billing period of the securities starts from November 21, 2026 through October 21, 2030. The bonds have a maturity date of November 21, 2030. The transaction is expected to close on November 21, 2025.
Reported Earnings • Aug 19Second quarter 2025 earnings released: ₩0.076 loss per share (vs ₩27.00 loss in 2Q 2024)Second quarter 2025 results: ₩0.076 loss per share (improved from ₩27.00 loss in 2Q 2024). Revenue: ₩10.9b (up 23% from 2Q 2024). Net loss: ₩1.54m (loss narrowed 100% from 2Q 2024). Profit margin: 0% (up from net loss in 2Q 2024). The move to profitability was driven by higher revenue.
Reported Earnings • Mar 19Full year 2024 earnings released: ₩189 loss per share (vs ₩259 profit in FY 2023)Full year 2024 results: ₩189 loss per share (down from ₩259 profit in FY 2023). Revenue: ₩32.4b (down 31% from FY 2023). Net loss: ₩3.71b (down 176% from profit in FY 2023).
공시 • Mar 07NanoTIM Co. Ltd., Annual General Meeting, Mar 24, 2025NanoTIM Co. Ltd., Annual General Meeting, Mar 24, 2025, at 10:00 Tokyo Standard Time. Location: auditorium, 14, gukjegwahak 2-ro, yuseong-gu, daejeon South Korea
New Risk • Nov 20New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩135.5b (US$97.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.3% operating cash flow to total debt). Revenue has declined by 23% over the past year. Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (3.0% increase in shares outstanding). Market cap is less than US$100m (₩135.5b market cap, or US$97.0m).
Reported Earnings • Nov 13Third quarter 2024 earnings released: ₩94.00 loss per share (vs ₩35.00 profit in 3Q 2023)Third quarter 2024 results: ₩94.00 loss per share (down from ₩35.00 profit in 3Q 2023). Revenue: ₩6.79b (down 36% from 3Q 2023). Net loss: ₩1.83b (down 380% from profit in 3Q 2023).
분석 기사 • Oct 25Some Investors May Be Worried About NanoTIM's (KOSDAQ:417010) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
분석 기사 • Aug 25Is NanoTIM (KOSDAQ:417010) A Risky Investment?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Reported Earnings • Aug 13Second quarter 2024 earnings released: ₩27.00 loss per share (vs ₩77.00 profit in 2Q 2023)Second quarter 2024 results: ₩27.00 loss per share (down from ₩77.00 profit in 2Q 2023). Revenue: ₩8.87b (down 32% from 2Q 2023). Net loss: ₩522.9m (down 135% from profit in 2Q 2023).
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₩9,980, the stock trades at a trailing P/E ratio of 52.9x. Average trailing P/E is 13x in the Chemicals industry in South Korea. Total loss to shareholders of 53% over the past year.
Buy Or Sell Opportunity • Jul 07Now 27% undervalued after recent price dropOver the last 90 days, the stock has fallen 2.4% to ₩13,080. The fair value is estimated to be ₩17,912, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jul 05Now 27% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to ₩13,080. The fair value is estimated to be ₩17,927, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jul 05Now 27% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.5% to ₩13,050. The fair value is estimated to be ₩17,926, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jul 05Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.5% to ₩13,050. The fair value is estimated to be ₩17,733, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jul 04Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 7.3% to ₩13,190. The fair value is estimated to be ₩17,754, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jul 02Now 26% undervalued after recent price dropOver the last 90 days, the stock has fallen 10% to ₩13,190. The fair value is estimated to be ₩17,756, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jul 01Now 23% undervalued after recent price dropOver the last 90 days, the stock has fallen 5.0% to ₩13,730. The fair value is estimated to be ₩17,762, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • Jun 21Now 21% undervaluedOver the last 90 days, the stock has risen 1.4% to ₩14,000. The fair value is estimated to be ₩17,716, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year, while earnings per share has been flat.
Buy Or Sell Opportunity • May 31Now 21% undervaluedOver the last 90 days, the stock has risen 12% to ₩13,910. The fair value is estimated to be ₩17,599, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.1% over the last year. Earnings per share has grown by 2.5%.
New Risk • Mar 22New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (50% accrual ratio). Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (3.0% increase in shares outstanding).
분석 기사 • Mar 21We Think You Should Be Aware Of Some Concerning Factors In NanoTIM's (KOSDAQ:417010) EarningsNanoTIM Co. Ltd.'s ( KOSDAQ:417010 ) stock didn't jump after it announced some healthy earnings. We did some digging...
New Risk • Nov 06New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risk Share price has been volatile over the past 3 months (8.9% average weekly change).